Clinical Trials

Zydus an innovation-driven, global pharmaceutical company, announced that it's plasmid DNA vaccine candidate for COVID-19 (ZyCoV-D) developed indigenously at its Vaccine Technology Centre in Ahmedabad, India has successfully completed the preclinical phase and has now received permission from the...

ERT, the global leader in clinical endpoints data collection, announced a strategic partnership with Inofab Health, a healthcare technology company designing and developing ultrasonic spirometry technology for in-clinic and at-home use. Through the partnership, ERT expands its portfolio of...

Avalon GloboCare Corp., a clinical-stage global developer of cell-based technologies and therapeutics, announced it has successfully completed Phase I first-in-human clinical study of its leading Chimeric Antigen Receptor (CAR) T-cell therapy candidate, AVA-001 (National Institute of Health clinical trial...

Samsung Bioepis  announced the initiation of Phase 3 clinical trial for SB15, the company's proposed biosimilar referencing Eylea® (aflibercept). The Phase 3 clinical trial for SB15 (aflibercept) is a randomised, double-masked, parallel group, multicenter study to compare the efficacy,...

AstraZeneca announced that selumetinib has been granted orphan drug designation (ODD) in Japan for the treatment of neurofibromatosis type 1 (NF1), a rare and debilitating genetic disease. Selumetinib is co-developed and co-commercialised with MSD Inc., Kenilworth, N.J., US (MSD: known...

LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, announced that Covance, its drug development business, has deployed the Xcellerate® COVID-19 solution as part of its award-winning Xcellerate platform. Covance has developed a...

Bharat Biotech has successfully developed COVAXIN™, India’s 1stvaccine candidate for COVID-19, in collaboration with the Indian Council of Medical Research (ICMR) -National Institute of Virology (NIV). The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech....